CN(CC(=O)Nc1ccc(Cl)c(C(F)(F)F)c1)C(=O)CCN1C(=O)C2CCCCC2C1=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?